Kent W. Jones , M.D.
Kent W. Jones , M.D. |
|
Current Titles:
Clinical Professor of Surgery, University of Utah College of Medicine
Chairman, Division of Cardiovascular and Thoracic Surgery, Intermountain Medical Center
Clinical Interests:
Valvular heart disease
Coronary artery disease
Arrhythmia surgery
Research Interests:
Clinical evaluation of bioprosthetic valves
Hyperglycemia in cardiac surgery
Society Memberships:
American Association for Thoracic Surgery
American Arbitration Association
American College of Surgery - Fellow
American Heart Association, Council on Cardiovascular Surgery
American Medical Association
Intermountain Thoracic Society,
President, 1980-81
Salt Lake County Medical Society
Salt Lake Surgical Society
Society of Thoracic Surgeons
Utah Certified Surgeons
Utah Heart Association,
President, 1989-90
Utah State Medical Association
Western Thoracic Surgical Association,
President, 1998-99
2. Jones KW, Jones M, Colvin SD, Allen SI, Michaelis LL: Experimental infundibular pulmonic stenosis. J Thorac Cardiovasc Surg 1974; 67:699.
3. Stinson EB, Tecklenburg PL, Hollingsworth JF, Jones KW, Sloane R, Rahmoeller G: Changes in left ventricular mechanical and hemodynamic function during acute rejection of orthotopically transplanted hearts in dogs. J Thorac Cardiovasc Surg 1974; 68:783.
4. Sabiston DC Jr, Wolfe WG, Oldham HN Jr., Wechsler AS, Crawford FA Jr, Jones KW, Jones RH: Surgical management of chronic pulmonary embolism. Ann Surg 1977; 185:699-712.
5. Kleinman LH, Hill RC, Chitwood WR, Hammon JW, Jones KW, Wechsler AS: Regional myocardial dimensions following coronary artery bypass grafting in patients: The relationship of functional deterioration to graft occlusion. J Thorac Cardiovasc Surg 1979; 77:13-23.
6. Jones KW: Thoracic trauma. Surgical Clinics of North America 1980; 60:957.
7. Jones KW: Arterial grafting techniques for replacement of major neck muscles. Chapter on Vascular Lesions of the Head and Neck. Special issue of Ear, Nose and Throat, Journal 1982 (June); Vol 61, No. 6.
8. Jones KW: Thoracic trauma in children. In Emergency Management of Pediatric Trauma, edited by T.A. Mayer: W.B. Saunders Co., Philadelphia, PA, 1985.
9. Burton NA, Gay WA Jr, Jones KW, Bristow MR, Karwande SV, Doty DB, Sorensen SG, Burke JL, Anderson JL, Lappé DL, Laser JA, Eiswirth CC, Gilbert EM: Heart transplantation in Utah: results of a multi-institutional program. J Heart Lung Transplant 1986; 5:69-70.
10. Miller R, Burton NA, Karwande SV, Jones KW, Doty DB, Gay WA: Early, aggressive open lung biopsy in heart transplant recipients. J Heart Lung Transplant 1987; 6:96-99.
11. Renlund DG, Gilbert EM, O’Connell JB, Gay WA, Jones KW, Burton NA, Doty DB, Karwande SV, DeWitt CW, Menlove RL, Herrick CM, Bristow MR: Age-associated decline in cardiac allograft rejection. Am J Med 1987; 83:391-98.
12. Renlund DG, Bristow MR, Burton NA, Jones KW, Karwande SV, Gay WA Jr: Survival following cardiac transplantation: what are acceptable standards? Western J Med 1987; 148(5):627-30.
13. Gilbert EM, Bristow MR, Renlund DG, O’Connell JB, Watson F, Jones KW, Gay WA Jr: OKT3 monoclonal antibody is superior to antithymocyte globulin for early prophylaxis in cardiac transplantation. Circulation 1987; 76(Suppl IV):256.
14. Crandall BG, Renlund DG, O’Connell JB, Burton NA, Jones KW, Gay WA, Doty DB, Karwande SV, Lee HR, Holland C, Menlove RL, Hammond E, Bristow MR: Increased cardiac allograft rejection in female heart transplant recipients. J Heart Lung Transplant 1988; 7:419-23.
15. Renlund DG, O’Connell JB, Gilbert EM, Burton NA, Jones KW, Karwande SV, Menlove RL, Gay WA Jr, Bristow MR: Comparison of OKT3- versus ATG-based early prophylaxis: decreased rejection and corticosteroid use with OKT3. J Heart Lung Transplant 1988; 7:69.
16. Hegewald MG, O’Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR: OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppression prophylaxis in cardiac transplantation. J Heart Lung Transplant 1989; 8:303-10.
17. Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WA Jr, Jones KW, O’Connell JB: Vascular (humoral) rejection in cardiac transplantation: pathologic observations and clinical implications. J Heart Lung Transplant 1989; 8:430-43.
18. O’Connell JB, Rasmussen LG, Ratkovec RM, Gay WA Jr, Jones KW, Renlund DG: Long-term cardiac allograft hemodynamic function with corticosteroid-free immunosuppression. Circulation 1989; 80:II-640.
19. Renlund DG, Bristow MR, Crandall BG, Burton NA, Doty DB, Karwande SV, Gay WA, Jones KW, Hegewald MG, Hagan ME, Lee HR, O’Connell JB: Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression. J Heart Lung Transplant 1989; 8:214-19.
20. Renlund DG, O’Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM, Lee HR, Gay WA, Bristow MR: A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation: decreased rejection and less corticosteroid use with OKT3. Transplantation 1989; 47:599-605.
21. Doty DB, Renlund DG, Caputo GR, Burton NA, Jones KW: Cardiac transplant in situs inversus. J Thorac Cardiovasc Surg 1990;99:493-99.
22. Doty DB, Doty JR, Jones KW: Bypass of superior vena cava: fifteen years experience with spiral vein graft for obstruction of superior vena cava due to benign disease. J Thorac Cardiovasc Surg 1990; 99:889-96.
23. Ratkovec RM, Wray RB, Renlund DG, O’Connell JB, Bristow MR, Gay WA, Karwande SV, Doty DB, Millar RC, Menlove RL, Burke JL, Lappe DL, Tsagaris TJ, Sutton RB, Jones KW: Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease following cardiac transplantation. J Thorac Cardiovasc Surg 1990; 100:6-12.
24. Merrell SW, Ames SC, Nelson EW, Renlund DG, Karwande SV, Burton NA, Sullivan JJ, Jones KW, Gay WA Jr: Major abdominal complications following cardiac transplantation. Arch Surg 1989; 124:889-94.
25. O’Connell JB, Bristow MR, Rasmussen LG, Ratkovec RM, Gay WA Jr, Jones KW, Renlund DG: Cardiac allograft function with corticosteroid-free maintenance immunosuppression. Circulation 1990; 82(Suppl IV):IV-318-IV-321.
26. Renlund DG, O’Connell JB, Ratkovec RM, Jones KW, Gay WA Jr, Karwande SV, Richenbacher WE, Doty DB, Millar RC, Bristow MR: Exclusion of the older heart transplant candidate from consideration: lack of medical justification. J Heart Lung Transplant 1990; 9:56.
27. Woodley SL, O’Connell JB, Renlund DG, Herrick CM, Gay WA Jr, Jones KW, Moore CK, Bristow MR: Safety and efficacy of intraoperative versus postoperative administration of OKT3 in orthotopic cardiac transplantation. J Am Coll Cardiol 1990; 15:69A.
28. Woodley SL, O’Connell JB, Renlund DG, Herrick CM, Millar RC, Karwande SV, Doty DB, Gay WA Jr, Jones KW, Moore CK, Bristow MR: Intermediate follow-up of intraoperative versus postoperative administration of OKT3 in orthotopic cardiac transplantation. J Heart Lung Transplant 1990; 9:61.
29. Hershberger RE, Nimer LR, O’Connell JB, Murray JL, Wong WA, Ratkovec RM, Gay WA Jr, Jones KW, Doty DB, Karwande SV, Millar RC, Richenbacher WE, Bristow MR: Use of progressively older donor cardiac allografts. J Heart Lung Transplant 1990; 9:57.
30. O’Connell JB, Renlund DG, Hammond EH, Witter CT, Yowell RL, DeWitt CW, Jones KW, Gay WA Jr, Menlove RL, Bristow MR: Sensitization to murine monoclonal anti-CD3 antibody (OKT3) in cardiac transplantation: correlation with early allograft loss. J Heart Lung Transplant 1991; 10(2):217-22.
31. Marks JD, Karwande SV, Richenbacher WE, Jones KW, Doty DB, Millar RC, O’Connell JB, Renlund DG, Bristow MR, Pantalos GM, Gay WA Jr: Perioperative mechanical circulation support for transplantation. J Heart Lung Transplant 1992; 11:117-128.
32. O’Connell JB, Renlund DG, Gay WA, DeWitt CW, Hammond EH, Yowell RL, Jones KW, Karwande SV, Doty DB, Bristow MR: Efficacy of OKT3 retreatment for refractory cardiac allograft rejection. Transplantation 1989; 47:788-92.
33. Ratkovec RM, O’Connell JB, Bristow MR, Jones KW, Gay WA Jr, Rasmussen LG, Renlund DG: Post-transplant lymphoproliferative disease in cardiac transplant patients receiving OKT3 therapy. Clinical Transplantation 1992; 6(2):260-64.
34. Hammond EH, Yowell RL, Nunoda S, Price GD, Menlove RL, Olsen SL, O’Connell JB, Bristow MR, Doty DB, Millar RC, Harwande SV, Jones KW, Gay WA Jr, Renlund DG: Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 1992; 11:S111-S119.
35. Ensley RD, Bristow MR, Olsen SL, Taylor DO, Hammond EH, O’Connell JB, Jones KW, Kauffman RS, Gay WA Jr: Use of mycophenolate mofetil (R-61443) in human heart transplant recipients. Transplantation 1993; 56:75-82.
36. DeBruyne LA, Ensley RD, Olsen SL, Taylor DO, Carpenter BM, Holland C, Swanson S, Jones KW, Karwande SV, Renlund DG, Bishop DK: Increased frequency of donor alloantigen-reactive helper T lymphocytes is associated with human cardiac allograft rejection. Transplantation 1993; 56:722-27.
37. Bull DA, Stahl RD, McMahan RN, Jones KW, Hawkins JA, Renlund DG, Taylor DO, Karwande SV: The high risk heart donor: potential pitfalls. J Heart Lung Transplant 1995; 14:424-28.
38. Taylor DO, Bristow MR, O’Connell JB, Price GD, Hammond EH, Doty DB, Karwande SV, Gay WA Jr, Jones KW, Lappe DL, Renlund DG: Improved long-term survival after cardiac transplantation predicted by successful early withdrawal from maintenance corticosteroids. J Heart Lung Transplant 1996; 15:1039-46.
39. Bull DA, Karwande SV, Hawkins JA, Neumayer LA, Taylor DO, Jones KW, Renlund DG, Putnam CW: Long-term results of cardiac transplantation in patients older than sixty years. J Thorac Cardiovasac Surg 1996; 111:423-28.
40. Jones KW: Twenty-five years of excellence: the legacy and the challenge. J Thorac Cardiovasc Surg 2000; 119(2):203-09.
41. Bertin KC, Rice RS, Doty DB, Jones KW: Repair of transverse sternal nonunions using metal plates and autogenous bone graft. Ann Thorac Surg 2002; 73(5):1661-62.
42. Schaff HV, Carrel TP, Jamieson WR, Jones KW, Rufilanchas JJ, Cooley DA, Hetzer R, Stumpe F, Duveau D, Moseley P, VanBoven WJ, Grunkemeier GL, Kennard ED, Holubkov R. Paravalvular leak and other events in silzone-coated mechanical heart Valves: a report from AVERT. Ann Thorac Surg 2002; 73(3):785-92.
43. Jones HU, Muhlestein JB, Jones KW, Bair TL, Lavasani F, Sohrevardi M, Horne BD, Doty DB, Lappe DL: Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open heart surgery in patients who present with an acute coronary syndrome. Circulation 2002;106[Suppl I]:I-19-22.
44. Jones HU, Muhlestein JB, Jones KW, Renlund DG, Bair TL, Bunch TJ, Horne BD, Lappe DL, Anderson JL, Doty DB: Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding. Ann Thorac Surg 2005; 80:518-22.